tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Mereo Biopharma: Depressed Valuation and Cost Controls Offset Setrusumab Trial Setback, Supporting Buy Rating on Upcoming Catalysts
PremiumRatingsMereo Biopharma: Depressed Valuation and Cost Controls Offset Setrusumab Trial Setback, Supporting Buy Rating on Upcoming Catalysts
15d ago
Mereo BioPharma downgraded to Hold from Buy at Jefferies
Premium
The Fly
Mereo BioPharma downgraded to Hold from Buy at Jefferies
15d ago
Ultragenyx price target lowered to $63 from $114 at Jefferies
Premium
The Fly
Ultragenyx price target lowered to $63 from $114 at Jefferies
15d ago
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Monday’s Biggest Stock Market Stories!
16d ago
Mereo Biopharma Stock (MREO) Collapses over 90% after Failed Trials
Premium
Market News
Mereo Biopharma Stock (MREO) Collapses over 90% after Failed Trials
16d ago
Mereo Biopharma Updates Setrusumab Trials and Cost Controls
Premium
Company Announcements
Mereo Biopharma Updates Setrusumab Trials and Cost Controls
16d ago
Mereo BioPharma management to meet virtually with Cantor Fitzgerald
PremiumThe FlyMereo BioPharma management to meet virtually with Cantor Fitzgerald
1M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100